Jane Street Group (NASDAQ: CORZ) reports 23.97M shares (7.5%) disclosed
Rhea-AI Filing Summary
Jane Street Group, LLC reports beneficial ownership of 23,967,780 shares of Core Scientific, Inc./tx common stock, representing 7.5% of the class. The filing identifies subsidiary holdings: Jane Street Capital, LLC (20,703,298 shares; 6.5%) and Jane Street Global Trading, LLC (3,264,482 shares; 1.0%). The statement shows shared voting and shared dispositive power over the 23,967,780 shares and is signed by Jeremy Kahn as authorized signatory.
Positive
- None.
Negative
- None.
Insights
Large passive stake disclosed by Jane Street affiliates; positions are shared across subsidiaries.
The Schedule 13G lists 23,967,780 shares as beneficially owned (7.5%), with shared voting and dispositive power. The filing attributes most shares to Jane Street Capital, LLC (20,703,298) and a smaller tranche to Jane Street Global Trading, LLC (3,264,482).
Cash‑flow treatment and any planned transactions are not stated in the excerpt; subsequent filings would show if the position is passive or active.
Shared control flags coordinated ownership but no indication of control change.
The cover data show shared voting power and shared dispositive power for the entire 23,967,780 share position. The filing is presented under Schedule 13G classification and signed by an authorized representative.
Because the stake is 7.5%, it does not by itself assert a controlling interest; material governance implications depend on subsequent disclosures or intent statements.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
AI-generated analysis. How Rhea-AI works. Not financial advice.